Drug intelligence / Profile preview

hailong jiao

Development stage: Unknown
Lead developer: Dong-E-E-Jiao
Administration: Oral

Overview

Hailong Jiao is a Traditional Chinese Medicine (TCM) derived from the gelatin of pipefish (Syngnathus), developed and manufactured by Shandong Dong'e Ejiao. It is primarily utilized in TCM to tonify the kidney yang, nourish the blood, and support reproductive health. The product is specifically indicated for conditions associated with kidney deficiency, such as impotence, infertility, and general physical debility. It is formulated as an oral solution (Hailong Jiao Oral Solution) and has received regulatory approval in China as part of Shandong Dong'e Ejiao's portfolio of specialized animal-derived gelatins.

Brand names: Hailong Jiao Oral Solution
Other names: 海龙胶Syngnathus gelatinPipefish gelatinColla Syngnathi

Beyond the preview

Go deeper on hailong jiao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on hailong jiao.

Explore the full profile